Loading…

Novel organophosphorus aminopyrimidines as unique structural DNA-targeting membrane active inhibitors towards drug-resistant methicillin-resistant Staphylococcus aureus

A series of novel unique structural organophosphorus aminopyrimidines were developed as potential DNA-targeting membrane active inhibitors through an efficient one-pot procedure from aldehydes, phosphonate and aminopyrimidine. The biological assay revealed that some of the prepared compounds display...

Full description

Saved in:
Bibliographic Details
Published in:MedChemComm 2018-09, Vol.9 (9), p.1529-1537
Main Authors: Li, Di, Bheemanaboina, Rammohan R Yadav, Battini, Narsaiah, Tangadanchu, Vijai Kumar Reddy, Fang, Xian-Fu, Zhou, Cheng-He
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A series of novel unique structural organophosphorus aminopyrimidines were developed as potential DNA-targeting membrane active inhibitors through an efficient one-pot procedure from aldehydes, phosphonate and aminopyrimidine. The biological assay revealed that some of the prepared compounds displayed antibacterial activities. In particular, imidazole derivative exhibited more potent inhibitory activity against MRSA with an MIC value of 4 μg mL in comparison with the clinical drugs chloromycin and norfloxacin. Experiments revealed that the active molecule had the ability to rapidly kill the tested strains without obviously triggering the development of bacterial resistance, showed low toxicity to L929 cells and could disturb the cell membrane. The molecular docking study discovered that compound could bind with DNA gyrase hydrogen bonds and other weak interactions. Further exploration disclosed that the active molecule could also effectively intercalate into MRSA DNA and form a steady -DNA supramolecular complex, which might further block DNA replication to exert powerful antibacterial effects.
ISSN:2040-2503
2040-2511
DOI:10.1039/c8md00301g